However, more impressively combining a single dose of the Nrf2 activator (increasing antioxidant defenses) and a single dose of an NADPH oxidase inhibitor (decreasing ROS production) following status epilepticus was neuroprotectant and prevented the later development of epilepsy in 70% of animals (Figure 3). The gene discussed is FMO5; the disease is epilepsy.